Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Ning J et al. | 1992 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), Daudi (Burkitt's lymphoma cell line) cells and normal human lymphocytes | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.1 mT |
| Masiuk M et al. | 2008 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), K-562 (chronic myelogenous leukemia) | magnetic field, 50/60 Hz | 10–20 mT |
| Jin M et al. | 1997 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), two different populations: Columbia University Cancer Center (CUCC), American Type Culture Collection (ATCC) | magnetic field, 50/60 Hz | 8 µT |
| Lin H et al. | 1998 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells), MCF-7, T-47D, and HTB-124 cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz | 8 µT |
| Lacy-Hulbert A et al. | 1995 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 0.1–100 µT |
| Greene JJ et al. | 1991 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | electric field, magnetic field, 50/60 Hz | 1 mT |
| Pipkin JL et al. | 1999 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 100 µT–1 mT |
| Greene JJ et al. | 1993 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 1 mT |
| Balcer-Kubiczek EK et al. | 2000 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
| Lin H et al. | 1995 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 6.7 µT |
| Goodman R et al. | 1994 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) and yeast cells (<i>Saccharomyces cerevisiae</i>) | electric field, magnetic field, 50/60 Hz | 0.1–80 µT |
| Nie K et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line), MCF-7 cells (breast cancer cell line), 3Y1 cells (rat fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
| Loberg LI et al. | 2000 | intact cell/cell culture, HME (human mammary epithelial cells), HBL-100 (transformed human mammary epithelial cells), HL-60 (human promyelocytic leukemia) | magnetic field, 50/60 Hz | 0.01–1 mT |
| Vianale G et al. | 2008 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1 mT |
| Patruno A et al. | 2010 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz, electrotherapy | 1 mT |
| Patruno A et al. | 2015 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Huang CY et al. | 2014 | intact cell/cell culture, HaCaT cells (human keratinocytes) partially transfected with CHK2 siRNA | magnetic field, 50/60 Hz, shielding/field deprivation | 1.5 mT |
| D'Angelo C et al. | 2015 | intact cell/cell culture, HaCaT cells (human keratinocytes), SH-SY5Y cells (human neuroblastoma cell line),THP-1 cells (human monocytic leukemia cell line), K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1 mT |
| Rao S et al. | 1996 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | magnetic field, 50/60 Hz | 6 µT |
| Lin H et al. | 1994 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | electric field, magnetic field, 50/60 Hz, shielding/field deprivation | 8–80 µT |
| Lin H et al. | 1999 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | magnetic field, 50/60 Hz | 8 µT |
| Lin H et al. | 2001 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | magnetic field, 50/60 Hz | 8 µT |
| Manzella N et al. | 2015 | intact cell/cell culture, HuDe cells (human dermal fibroblasts) | magnetic field, 50/60 Hz | 0.1 mT |
| Rao RR et al. | 2002 | intact cell/cell culture, IMR 32 (human neuroblastoma cells) | magnetic field, 50/60 Hz | 50–200 µT |
| Heredia-Rojas JA et al. | 2010 | intact cell/cell culture, INER-37 (human non-small-cell lung cancer cell line) and RMA E7 cells (E7-transfected mouse RMA lymphoma cells), transfected with the plasmid pEMF (electromagnetic field plasmid containing hsp70 promotor and the luciferase gene as reporter gene) | magnetic field, 50/60 Hz | 8–80 µT |
| Still M et al. | 2002 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz, DC, static magnetic field | 10–100 µT |
| Patruno A et al. | 2015 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1 mT |
| Jedrzejczak-Silicka M et al. | 2021 | intact cell/cell culture, L929 cells (murine fibroblast cells) and HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz, low frequency | 5.9–28.4 mT |
| Girgert R et al. | 2008 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Girgert R et al. | 2009 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Li H et al. | 2005 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.4 mT |
| Sanie-Jahromi F et al. | 2016 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 0.25–0.5 mT |
| Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
| Mousavi M et al. | 2014 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 0.04 T |
| Mahmoudinasab H et al. | 2016 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.25–0.5 mT |
| Mahmoudinasab H et al. | 2016 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.25–0.5 mT |
| Lee HC et al. | 2015 | intact cell/cell culture, MCF10 A (human breast epithelial cell line), MCF7 (human breast cancer cell line), Jurkat cells (human lymphoblastoid T cell line), NIH3T3 (mouse embryonic fibroblast cell line) | magnetic field, 50/60 Hz | 0.1–2 mT |
| Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
| Domínguez G et al. | 2021 | intact cell/cell culture, MDCK cells (Madin-Darby canine kidney cell line) | magnetic field, 50/60 Hz | 1–5 mT |
| Ding GR et al. | 2000 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Ding GR et al. | 2002 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Somosy Z et al. | 2004 | intact cell/cell culture, Madin-Darby canine kidney (MDCK) cells | magnetic field, 50/60 Hz | 500 µT |
| Uckun FM et al. | 1995 | intact cell/cell culture, NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz | 100 µT |
| Martínez MA et al. | 2021 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | 50/60 Hz, magnetic field | 100 µT |
| Martínez MA et al. | 2022 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | 50/60 Hz, magnetic field | - |
| Campbell-Beachler M et al. | 1998 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 12.5–100 µT |
| Wang Z et al. | 2024 | intact cell/cell culture, RSC96 cells, animal, rat/Sprague Dawley | 50/60 Hz, magnetic field, signals/pulses, also other exposures without EMF, co-exposure | - |
| Kanitz MH et al. | 2007 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, 50/60 Hz, electrotherapy, therapeutic/medical device | 1.2 µT |
| Savage Jr RE et al. | 2005 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
